Despite advances in treatment for inflammatory bowel disease, more than 55% of patients report medication delays, mostly due ...

The Vancouver-based company uses generative AI to create biologic drugs, with 20 “active programs” underway, many of them ...

Not all fiber is created equal when it comes to gut issues. Certain fiber types can provoke symptoms, while others aid in ...

Many insured US patients living with IBD face challenges to health care access, which has resulted in them skipping or rationing medication.

Armed with positive data from a phase 2b trial, Teva and Sanofi have decided to push their anti-TL1A antibody duvakitug into a phase 3 programme in inflammatory bowel disease (IBD). The results of ...

Older adults with moderate to severe IBD can achieve remission with JAK inhibitors, according to a study presented at Crohn’s & Colitis Congress.

Skin disorders are a common extraintestinal symptom of inflammatory bowel disease (IBD), occurring in up to 25% of people with ulcerative colitis and Crohn's disease. Some of these skin conditions are ...